CAS 100239-44-9
:3α-Hidroxitibolona
- (3A,7A,17A)-3,17-Dihydroxy-7-Methyl-19-Norpregn-5(10)-En-20-Yl-3-One
- (3α,7α,17α)-7-Methyl-19-norpregn-5(10)-en-20-yne-3,17-diol
- 19-Norpregn-5(10)-en-20-yne-3,17-diol, 7-methyl-, (3α,7α,17α)-
- 3-alpha-Hydroxytibolone
- Org 4094
- 3α-Hydroxytibolone
3alpha-Hydroxy Tibolone
CAS:Produto ControladoApplications A metabolite of Tibolone. A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome.
References Belman, S., et al.: Cancer Res., 32, 450 (1972), Shirahashi, H., et al.: Chem. Pharm. Bull., 41, 1664 (1993), Hoyte, R., et al.: Steroids, 58, 13 (1993), Sandker, G., et al.: Xenobiotica, 24, 143 (1994), Colombo, D., et al.: Eur. J. Med. Chem., 40, 69 (2005),Fórmula:C21H30O2Cor e Forma:White To Off-WhitePeso molecular:314.463-Hydroxy Tibolone-d5 (mixture of 3Alpha & 3Beta isomers)
CAS:Produto ControladoApplications 3-Hydroxy Tibolone-d5, is the labeled analogue of 3-Hydroxy Tibolone, a synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Belman, S., et al.: Cancer Res., 32, 450 (1972), Shirahashi, H., et al.: Chem. Pharm. Bull., 41, 1664 (1993), Hoyte, R., et al.: Steroids, 58, 13 (1993), Sandker, G., et al.: Xenobiotica, 24, 143 (1994), Colombo, D., et al.: Eur. J. Med. Chem., 40, 69 (2005),Fórmula:C21H25D5O2Cor e Forma:NeatPeso molecular:319.493α-Hydroxy Tibolone (1mg/ml in Acetonitrile)
CAS:Produto ControladoFórmula:C21H30O2Cor e Forma:Single SolutionPeso molecular:314.463α-Hydroxy Tibolone-13C,d3 (1mg/ml in Acetonitrile)
CAS:Produto ControladoFórmula:C2013CH27D3O2Cor e Forma:Single SolutionPeso molecular:318.473a-Hydroxy Tibolone-13C,d3
CAS:Produto ControladoFórmula:C2013CH27D3O2Cor e Forma:NeatPeso molecular:318.473a-Hydroxy tibolone
CAS:Produto ControladoTibolone is a synthetic hormone that is used in the treatment of menopausal symptoms and breast cancer. Tibolone has been shown to be an effective treatment for menopausal symptoms, such as hot flashes and vaginal dryness, by providing relief from these symptoms. Tibolone has also been shown to have anti-cancer effects. This drug may be useful for treating breast cancer because it can inhibit the growth of cancer cells by binding to estrogen receptors and blocking estrogen-induced cell proliferation. Tibolone also stimulates angiogenesis, which is the formation of new blood vessels in order to provide nutrients and oxygen to growing tissue. It has been shown that this drug inhibits the synthesis of hepg2 cells in vitro, which are involved in the production of angiogenic factors. Tibolone may also have clinical relevance as a chemopreventive agent against prostate cancer.BR> Tibolone has also been shown to stimulate sulphatase activity in vitro, which may contribute to
Fórmula:C21H30O2Pureza:Min. 95%Peso molecular:314.46 g/molRef: 3D-FH24140
Produto descontinuado

